New treatments for tic disorders

Current Treatment Options in Neurology

Volumn 8, Issue 6, 2006, Pages 465-473

  Qasaymeh, Mohammad M ^b   Mink, Jonathan W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BACLOFEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; BROMOCRIPTINE; CARBAMAZEPINE; CHARCOAL; CLONIDINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; ETIRACETAM; FLUOXETINE; FLUPHENAZINE; FLUVOXAMINE; GUANFACINE; HALOPERIDOL; LEVODOPA; METHYLPHENIDATE; NARCOTIC ANALGESIC AGENT; OLANZAPINE; OMEPRAZOLE; PERGOLIDE; PIMOZIDE; PLACEBO; RIFAMPICIN; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZIPRASIDONE;

ACADEMIC ACHIEVEMENT; AKATHISIA; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BLURRED VISION; BODY TEMPERATURE DISORDER; BODY WEIGHT DISORDER; BRADYCARDIA; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; COMORBIDITY; CONFUSION; CONSTIPATION; DAILY LIFE ACTIVITY; DIET THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INHIBITION; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSTONIA; EUPHORIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEEDBACK SYSTEM; GALACTORRHEA; GYNECOMASTIA; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERPROLACTINEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INSOMNIA; JOB PERFORMANCE; LIFESTYLE; NEUROLEPTIC MALIGNANT SYNDROME; NIGHTMARE; OBSESSIVE COMPULSIVE DISORDER; PARKINSONISM; PATIENT EDUCATION; PHOTOSENSITIVITY; RECEPTOR AFFINITY; RELAXATION TRAINING; RESTLESSNESS; RETINOPATHY; SEIZURE; SELF MONITORING; SEXUAL DYSFUNCTION; SOMNOLENCE; SYMPTOM; TACHYCARDIA; TARDIVE DYSKINESIA; TIC; URTICARIA; VISUAL DISORDER; WEIGHT GAIN;

EID: 33750627638     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0036-4     Document Type: Article

References (41)

1. Leckman J, Cohen D: Tourette's Syndrome - Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. New York: John Wiley & Sons; 1999.
2. Leckman JF: Tourette's syndrome. Lancet 2002, 360:1577-1586.
3. Robertson M: Tourette syndrome: associated conditions and the complexities of treatment. Brain 2000, 123:425-462.
4. Kurlan R: Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders, edn 2. New York: Marcel Dekker; 2005.
5. Kurlan R, Como PG, Miller B, et al.: The behavioral spectrum of tic disorders: a community-based study. Neurology 2002, 59:414-420.
6. Robertson MM: Diagnosing Tourette syndrome: is it a common disorder? J Psychosom Res 2003, 55:3-6.
7. Snider LA, Seligman LD, Ketchen BR, et al.: Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 2002, 110:331-336.
8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
9. The Tourette Syndrome Classification Study Group: Definitions and classification of tic disorders. Arch Neurol, 1993, 50:1013-1016.
10. Piacentini J, Chang S: Habit reversal training for tic disorders in children and adolescents. Behav Modif 2005, 29:803-822.
11. Ackermans L, Temel Y, Cath D, et al.: Deep brain stimulation in Tourette's syndrome: two targets? Mov Disord 2006, 21:709-713.
12. Leckman J, Zhang H, Vitale A, et al.: Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998, 102:14-19.
13. Erenberg G, Cruse R, Rothner A: The natural history of Tourette syndrome: a follow-up study. Ann Neurol 1987, 22:383-385.
14. Hoekstra PJ, Steenhuis MP, Kallenberg CG, Minderaa RB: Association of small life events with self reports of tic severity in pediatric and adult tic disorder patients: a prospective longitudinal study. J Clin Psychiatry 2004, 65:426-431.
15. Wood BL, Klebba K, Gbadebo O, et al.: Pilot study of effect of emotional stimuli on tic severity in children with Tourette's syndrome Mov Disord 2003, 18:1392-1395.
16. Tourette Syndrome Study Group: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58:527-536.
17. Scahill L, Chappell PB, Kim YS, et al.: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1067-1074.
18. Bottai T, Quintin P, Perrin E: Antipsychotics and the risk of diabetes: a general data review. Eur Psychiatry 2005, 20(Suppl 4):S349-S357.
19. Scahill L, Leckman JF, Schultz RT, et al.: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60:1130-1135.
20. Dion Y, Annable L, Sandor P, Chouinard G: Risperidone in the treatment of Tourette syndrome: a doubleblind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22:31-39.
21. Gilbert DL, Batterson JR, Sethuraman G, Sallee FR: Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 2004, 43:206-214.
22. Gaffney GR, Perry PJ, Lund BC, et al.: Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 2002, 41:330-336.
23. Budman CL, Gayer A, Lesser M, et al.: An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry 2001, 62:290-294.
24. Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292-299.
25. Mukaddes NM, Abali O: Quetiapine treatment of children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol 2003, 13:295-299.
26. Murphy TK, Bengtson MA, Soto O, et al.: Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol 2005, 8:489-490.
27. Kastrup A, Schlotter W, Plewnia C, Bartels M: Treatment of tics in Tourette syndrome with aripiprazole. J Clin Psychopharmacol 2005, 25:94-96.
28. Ross MS, Moldofsky H: A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette syndrome. Am J Psychiatry 1978, 135:585-587.
29. Shapiro AK, Shapiro E: Controlled study of pimozide vs placebo in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1984, 23:161-173.
30. Shapiro E, Shapiro AK, Fulop G: Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989, 46:722-730.
31. Sallee FR, Nesbitt L, Jackson C: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 1997, 154:1057-1062.
32. Borison RL, Ang L, Chang S: New pharmacological approaches in the treatment of Tourette syndrome. Adv Neurol 1982, 35:377-382.
33. Goetz CG, Tanner CM, Klawans HL: Fluphenazine and multifocal tic disorders. Arch Neurol 1984, 41:271-272.
34. Gilbert DL, Dure L, Sethuraman G, et al.: Tic reduction with pergolide in a randomized controlled trial in children. Neurology 2003, 60:606-611.
35. Gilbert DL, Sethuraman G, Sine L, et al.: Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000, 54:1310-1315.
36. Porta M, Maggioni G, Ottaviani F, Schindler A: Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A. Neurol Sci 2004, 24:420-423.
37. Micheli F, Scorticati MC, Raina G: Beneficial effects of botulinum toxin type A for patients with painful tic convulsif. Clin Neuropharmacol 2002, 25:260-262.
38. Houeto JL, Karachi C, Mallet L, et al.: Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry 2005, 76:992-995.
39. Visser-Vandewalle V, Temel Y, Boon P, et al.: Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg 2003, 99:1094-1100.
40. Mink JW, Walkup J, Frey KA, et al.: Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006, In press.
41. Deckersbach T, Rauch S, Buhlmann U, Wilhelm S: Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther 2006, 44:1079-1090.